143 related articles for article (PubMed ID: 6666226)
1. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
Weidemann H; Schuon J; Schober B
Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
Becker HJ; Fach WA; Weil J; Hüwer HD
Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
[TBL] [Abstract][Full Text] [Related]
3. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Dorow P; Schiess W
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
[TBL] [Abstract][Full Text] [Related]
4. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
5. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
6. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
8. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
9. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
10. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
Vogler AC; Silber S; Vogel M; Theisen K
Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamics and coronary dynamics under ISDN long-term therapy].
Wortmann A; Bachmann K; Deuber HJ; Roth E
Z Kardiol; 1986; 75 Suppl 3():68-76. PubMed ID: 3798997
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
[TBL] [Abstract][Full Text] [Related]
15. Antianginal efficacy of long-term nitrate therapy.
Kenedi P; Giebeler B
Z Kardiol; 1983; 72 Suppl 3():233-8. PubMed ID: 6666227
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effect of subchronic therapy with 120 mg isosorbide dinitrate in a slow release form in minimal to moderate post-infarct heart failure].
Wolf R; Nötges A; Traber U
Z Kardiol; 1989; 78 Suppl 2():137-41; discussion 142-4. PubMed ID: 2686254
[TBL] [Abstract][Full Text] [Related]
17. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
19. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
Gloor HO; Angehrn W; Steinbrunn W
Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
[TBL] [Abstract][Full Text] [Related]
20. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
